Bharat Biotech's Krishna Ella suggests merging state drugs regulators with central body to ensure 'one quality one standard'

His comments came on Sunday in the backdrop of questions being raised about the quality of Indian drugs over the past few months. The latest instance was on Friday, when the Tamil Nadu-based Global Pharma Healthcare recalled its entire lot of eye drop linked allegedly to vision loss in the US.

from Industry-Economic Times https://ift.tt/LP46iS0
via IFTTT